CompletedNCT03235154
Epclusa for Hepatitis C in an Outpatient Addiction Clinic
About this title
Read the official source — NCT03235154Medication studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- SomervilleSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: October 11, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 11
- Sponsor
- Community Research Initiative of New England
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03235154
- Official title
Show the full official title
Bridging Care to HCV Treatment Among Opiate Dependent Patients on Buprenorphine/Naloxone Maintenance Therapy: A Pilot Study of Treating HCV With Epclusa at a Psychiatrist-staffed Outpatient Addiction Clinic
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Somerville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Community Research Initiative of New England.
Did this study involve medication?
Yes. The study involved medication, including sofosbuvir/velpatasvir.
Who was this study for?
Listed age limits: from 18 years.
